Agnes Yong

учебное заведение: Имперский колледж Лондона

род занятий: исследователь

Серия

There is nothing here

Создать новую серию

Произведения

There is nothing here

Создать новое произведение

Статьи 33

Дата

Заголовок

Авторы

2020-04-30

Successful treatment-free remission in chronic myeloid leukaemia and its association with reduced immune suppressors and increased natural killer cells

Chung H Kok, Timothy Hughes, Agnes Yong
2019-03-27

Lenalidomide maintenance treatment after imatinib discontinuation: results of a phase 1 clinical trial in chronic myeloid leukaemia

Давид Росс, Ilaria Stefania Pagani, Yazad Irani, John Reynolds, David S Ritchie, Deborah L. White, Susan Branford, Timothy Hughes, Agnes Yong
2018-03-19

Country-Level Macroeconomic Indicators Predict Early Post-Allogeneic Hematopoietic Cell Transplantation Survival in Acute Lymphoblastic Leukemia: A CIBMTR Analysis.

William Wood, Richard Olsson, Agnes Yong, Miguel Angel Diaz, Hillard M. Lazarus, Keith M. Sullivan, Jan Cerny, Sachiko Seo, Nandita Khera, Ruta Brazauskas
2017-04-24

Immune Effector Recovery in Chronic Myeloid Leukemia and Treatment-Free Remission

Agnes Yong
2017-01-03

CML patients with deep molecular responses to TKI have restored immune effectors and decreased PD-1 and immune suppressors

Deborah L. White, Agnes Yong
2017-01-09

Comment on "KB004, a first in class monoclonal antibody targeting the receptor tyrosine kinase EphA3, in patients with advanced hematologic malignancies: Results from a phase 1 study"

Angel F. Lopez, Agnes Yong
2016-02-25

Novel germ line DDX41 mutations define families with a lower age of MDS/AML onset and lymphoid malignancies

Anna L Brown, Andreas W Schreiber, Chan-Eng Chong, Agnes Yong, Мэри Кинг, Tom Walsh, Chris Hahn, Hamish S. Scott
2016-05-31

Human leukocyte antigen supertype matching after myeloablative hematopoietic cell transplantation with 7/8 matched unrelated donor allografts: a report from the Center for International Blood and Marrow Transplant Research

Richard Olsson, Agnes Yong, Christopher Dandoy, Kirk R Schultz, Stephen Spellman, Stephanie J. Lee, Michael R Verneris, Steven G. E. Marsh, Medhat Askar, Aleksandr Lazaryan, Machteld Oudshoorn, Daniel J Weisdorf, Gregory A Hale, Carlheinz R Müller, Joseph A Pidala, Menachem Bitan, Marcelo A. Fernández-Viña, Bipin N Savani, Mukta Arora, Taiga Nishihori, William R Drobyski
2015-03-30

Secondary solid cancer screening following hematopoietic cell transplantation

Helene Schoemans, Agnes Yong, Mary E D Flowers
2015-09-15

Sexual health in hematopoietic stem cell transplant recipients

Agnes Yong
2015-09-12

Transplant to treatment-free remission: the evolving view of 'cure' in chronic myeloid leukemia

Agnes Yong
2015-10-23

KIR2DL5B genotype predicts outcomes in CML patients treated with response-directed sequential imatinib/nilotinib strategy

David T Yeung, Deborah L. White, Susan Branford, Agnes Yong
2014-11-10

Clinical and biological predictors of outcome following relapse of CML post-allo-SCT

Sawa Ito, Christopher S Hourigan, Agnes Yong
2014-10-27

Achieving early molecular response in chronic myeloid leukemia in chronic phase to reduce the risk of progression: clinical relevance of the 3- and 6-month time points

Agnes Yong
2013-12-20

Monoclonal antibody targeting of IL-3 receptor α with CSL362 effectively depletes CML progenitor and stem cells

Hayley S. Ramshaw, Agnes Yong, Angel F. Lopez, Deborah L. White
2012-04-21

Directed therapy for patients with myelodysplastic syndromes (MDS) by suppression of cyclin D1 with ON 01910.Na

Kelsey Loeliger, Agnes Yong, Phillip Scheinberg
2011-12-24

Lymphodepletion is permissive to the development of spontaneous T-cell responses to the self-antigen PR1 early after allogeneic stem cell transplantation and in patients with acute myeloid leukemia undergoing WT1 peptide vaccination following chemotherapy

Agnes Yong, Stephan Mielke
2010-12-06

Repeated PR1 and WT1 peptide vaccination in Montanide-adjuvant fails to induce sustained high-avidity, epitope-specific CD8+ T cells in myeloid malignancies

Agnes Yong, Stephan Mielke
2010-11-19

T-cell immune responses to Wilms tumor 1 protein in myelodysplasia responsive to immunosuppressive therapy

Agnes Yong, Phillip Scheinberg, David A Price, Emma Gostick, Daniel C Douek, Jason M Brenchley
2008-06-12

Hematopoietic stem cells and progenitors of chronic myeloid leukemia express leukemia-associated antigens: implications for the graft-versus-leukemia effect and peptide vaccine-based immunotherapy

Agnes Yong
2008-11-06

Ex vivo characterization of polyclonal memory CD8+ T-cell responses to PRAME-specific peptides in patients with acute lymphoblastic leukemia and acute and chronic myeloid leukemia

Agnes Yong, Stephan Mielke
2008-06-18

Association between BMI-1 expression, acute graft-versus-host disease, and outcome following allogeneic stem cell transplantation from HLA-identical siblings in chronic myeloid leukemia

Richard Szydlo, Agnes Yong
2007-04-05

High PR3 or ELA2 expression by CD34+ cells in advanced-phase chronic myeloid leukemia is associated with improved outcome following allogeneic stem cell transplantation and may improve PR1 peptide-driven graft-versus-leukemia effects

Agnes Yong, Stephan Mielke
2007-05-03

Reconstitution of FOXP3+ regulatory T cells (Tregs) after CD25-depleted allotransplantation in elderly patients and association with acute graft-versus-host disease

Stephan Mielke, Agnes Yong, Ellen Vitetta, Victor Ghetie
2007-08-24

Absolute lymphocyte count on day 30 is a surrogate for robust hematopoietic recovery and strongly predicts outcome after T cell-depleted allogeneic stem cell transplantation

Stephan Mielke, Agnes Yong
2007-09-17

Leukemia-associated antigen-specific T-cell responses following combined PR1 and WT1 peptide vaccination in patients with myeloid malignancies

Agnes Yong, Stephan Mielke
2007-03-14

The polycomb group BMI1 gene is a molecular marker for predicting prognosis of chronic myeloid leukemia

Richard Szydlo, Agnes Yong
2007-08-02

Rapid natural killer cell recovery determines outcome after T-cell-depleted HLA-identical stem cell transplantation in patients with myeloid leukemias but not with acute lymphoblastic leukemia

Stephan Mielke, Agnes Yong
2005-09-06

Molecular profiling of CD34+ cells identifies low expression of CD7, along with high expression of proteinase 3 or elastase, as predictors of longer survival in patients with CML

Richard Szydlo, Agnes Yong
2001-12-01

Molecular studies in patients with chronic myeloid leukaemia in remission 5 years after allogeneic stem cell transplant define the risk of subsequent relapse

Agnes Yong, Richard Szydlo, Николас Кросс, Charles Craddock, Frits van Rhee
2001-01-01

Cytomegalovirus seropositivity adversely influences outcome after T-depleted unrelated donor transplant in patients with chronic myeloid leukaemia: the case for tailored graft-versus-host disease prophylaxis

Charles Craddock, Richard Szydlo, Francesco Dazzi, Agnes Yong
1999-04-01

Relapse of chronic myeloid leukaemia 14 years after allogeneic bone marrow transplantation

Agnes Yong

Human - wd:Q56900853

Добро пожаловать в Inventaire

the library of your friends and communities

узнать больше